In addition to its current grants to support travel, lodging and living expenses to enable research professionals from resource-poor countries to study research ethics and management, WCGF has expanded grant opportunities to include grants for [...]
The reasons minority participants avoid clinical trials are well documented. Historical lack of consent, little diversity within the research team, and a percieved lack of relevance could all seem to push patients away. But researchers [...]
The Food & Drug Administration (FDA) has recently released a Manual of Policies and Procedures (MAPP) for the use of an investigational drug in an emergency - whether during or outside business hours. Because of [...]
Though the cells from breast cancer tumors of African American women and white women have an overwhelming number of similarities, aggressiveness of tumors and outcomes of the disease are drastically different. African American women are [...]
How many types of cells are in the human body? Two hundred? More? A researcher found a new way to take a census of cells.
There are around 37 trillion cells in the human body. But those can be categorized into how many types? A simple Google search will yield a result of about 200, but some researchers, including Jay [...]
How can patients, who often don’t enroll in clinical trials because they are far from home, join trials that could save their lives?
As the ubiquity and growing dependability of online communication grows, telemedicine has proven to be a boon for patients, especially those in rural areas where the number of physicians is dwindling. And, as discoveries in [...]
What is expanded access and how can a desperately ill patient find treatment through this process? Are there online tools available for navigating the steps needed?
Expanded access, also known as compassionate use, is a process by which a patient can petition both the maker of an experimental treatment and the US Food and Drug Administration for access to the treatment [...]
A new study from Bioethics International shows that a majority of drugs provided to very ill patients via the Food and Drug Administration's (FDA) expanded access program - 76% - eventually gain marketing approval from [...]
Leading cancer organizations have formed a coalition and provided recommendations to extend better care to minorities. What do they suggest?
A summit attended by healthcare experts and representatives from the National Institutes of Health (NIH), American Cancer Society, the American Society for Cancer Research (ASCR), and American Society of Clinical Oncology (ASCO) convened, producing a [...]
The Reagan-Udall Foundation Navigator: An Online Tool to Help Desperately Ill Patients Considering Compassionate Use Treatment Options
Expanded access, also known as compassionate use, is a process by which a patient can request both the manufacturer of an experimental product (treatment) and the US Food and Drug Administration for access to the [...]